AEHR Stock Cash Flow Statements

Aehr Test Systems Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Aehr Test Systems Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-02-29	2023-11-30	2023-08-31	2023-05-31	2023-02-28	2022-11-30	2022-08-31	2022-05-31	2022-02-28	2021-11-30	2021-08-31	2021-05-31	2021-02-28	2020-11-30	2020-08-31	2020-05-31	2020-02-29	2019-11-30	2019-08-31	2019-05-31	2019-02-28	2018-11-30	2018-08-31	2018-05-31	2018-02-28	2017-11-30	2017-08-31	2017-05-31	2017-02-28	2016-11-30	2016-08-31	2016-05-31	2016-02-29	2015-11-30	2015-08-31	2015-05-31	2015-02-28	2014-11-30	2014-08-31	2014-05-31	2014-02-28	2013-11-30	2013-08-31	2013-05-31	2013-02-28	2012-11-30	2012-08-31	2012-05-31	2012-02-29

cash flows from operating activities:
net income	-1,471,000	6,089,000	4,674,000	6,111,000	4,132,000	3,725,000	589,000	5,794,000	2,243,000	717,000	696,000	567,000	-735,000	-1,966,000	107,000	-2,885,000	245,000	251,000	-413,000	110,000	-3,201,000	-629,000	-1,515,000	191,000	267,000	60,000	10,000	-795,000	-2,651,000	-1,452,000	-755,000	-3,056,000	-2,975,000	-1,048,000	294,000	-1,900,000	-1,726,000	-2,114,000	-907,000	239,000	212,000	137,000	-166,000	-854,000	-1,458,000	-811,000	-296,000	-779,000	-1,361,000
adjustments to reconcile net income to net cash from operating activities:
stock-based compensation expense	584,000	638,000	522,000		592,000	793,000	710,000		880,000	718,000	588,000	303,000	271,000			299,000	207,000	205,000	199,000	200,000	225,000	224,000	256,000	174,000	242,000	364,000	216,000	208,000	257,000	215,000	319,000	230,000	213,000	254,000	319,000	304,000	219,000	277,000	197,000	204,000	235,000	247,000	143,000	174,000	201,000
depreciation and amortization	186,000	145,000	138,000	113,000	146,000	102,000	89,000	81,000	77,000	76,000	73,000	71,000	74,000	83,000	82,000	86,000	105,000	98,000	95,000	98,000	103,000	119,000	111,000	117,000	110,000	101,000	89,000	76,000	66,000	61,000	68,000	80,000	50,000	36,000	37,000	37,000	37,000	32,000	29,000	22,000	24,000	42,000	53,000	75,000	77,000	84,000	86,000	103,000	120,000
accretion of investment discount	0	0	-130,000	-271,000	-241,000
amortization of operating lease right-of-use assets	185,000
benefit from doubtful accounts				0	0																						31,000		4,000	-8,000	20,000														-20,000			25,000	-17,000
changes in operating assets and liabilities:
accounts receivable	-907,000	8,600,000	3,437,000				7,648,000	-4,380,000	-1,170,000	-3,179,000	895,000	-2,436,000	-1,278,000	-301,000	2,642,000	-199,000	1,732,000	-1,956,000	1,584,000	-2,914,000	1,939,000	-1,631,000	563,000	1,787,000	-1,119,000	1,852,000	-1,260,000	-2,388,000	-147,000	278,000	-1,250,000	1,479,000	604,000	61,000	-1,257,000	-810,000	639,000	673,000	1,272,000	-35,000	-627,000	158,000	-216,000	-1,157,000	1,248,000	-350,000	53,000	-1,820,000	1,196,000
inventories	-4,186,000	-2,292,000	-7,704,000	-2,686,000	-3,689,000	-771,000	-2,323,000	-1,225,000	-1,237,000	-2,888,000	-1,324,000	-623,000	718,000	-955,000	-112,000	1,321,000	470,000	-471,000	-156,000	9,000	814,000	-399,000	-536,000	319,000	-1,143,000	795,000	-2,044,000	233,000	-1,138,000	-39,000	1,374,000	345,000	41,000	-160,000	-156,000	-302,000	-825,000	275,000	-156,000	-194,000	-265,000			327,000	679,000	336,000	-640,000	-420,000	-72,000
prepaid expenses and other current assets	1,645,000	-2,335,000	90,000				-210,000				-201,000				80,000				194,000		-70,000	19,000	4,000		532,000	-46,000	-1,089,000			-86,000	-52,000
accounts payable	867,000	-4,160,000	-939,000	4,222,000	1,032,000	559,000	-769,000	912,000	-68,000	642,000	-130,000	1,799,000	-82,000	333,000	-173,000	9,000	-1,422,000	624,000	-235,000	1,342,000	-1,434,000	700,000	-398,000	-827,000	737,000	-1,656,000	651,000	960,000	5,000	8,000	713,000	-504,000	381,000	-426,000	1,113,000	-856,000	-119,000	395,000	-270,000	-368,000	364,000	536,000	175,000	-136,000	325,000	-431,000	485,000	464,000	-377,000
accrued expenses	100,000	-1,329,000	355,000	654,000	919,000	85,000	-1,130,000	1,089,000	271,000	273,000	-169,000	553,000	276,000	-30,000	-67,000	85,000	-236,000	17,000	-455,000	-29,000	606,000	-24,000	-151,000	31,000	26,000	26,000	-21,000	-272,000	526,000	-20,000	-181,000	105,000	-5,000	-66,000	505,000	-300,000	88,000	-197,000	38,000	-33,000	191,000	-190,000	7,000
deferred revenue	335,000	-5,997,000	3,294,000
operating lease liabilities	-168,000	-61,000	-28,000
income taxes payable	6,000	-8,000	20,000	-1,000	5,000	2,000	2,000	-12,000	7,000	8,000	3,000	-13,000	2,000	0	1,000	-21,000	15,000	1,000	3,000	-20,000	-9,000	14,000	4,000	-23,000	4,000	11,000	-20,000	-21,000	2,000	23,000	-2,000	-16,000	-34,000	11,000	-2,000	-36,000	57,000	17,000	-53,000
net cash from operating activities	-2,824,000	-545,000	3,901,000	5,868,000	-1,123,000	-195,000	5,461,000	-767,000	-2,936,000	3,337,000	1,874,000	-190,000	-256,000	-2,898,000	643,000	-1,384,000	-364,000	-86,000	-190,000	-844,000	-1,836,000	-1,986,000	-971,000	1,745,000	-943,000	1,724,000	-3,877,000	-27,000	-3,052,000			-1,574,000	-854,000	-1,757,000	-2,096,000	-616,000	-797,000	-625,000	-218,000		-604,000	263,000	172,000
capex	-263,000	-156,000	-284,000	-1,184,000	-79,000	-15,000	-84,000	-198,000	-86,000	-73,000	-59,000	-22,000	-11,000	-147,000	-47,000	-12,000	-28,000	-73,000	-50,000	-49,000	-21,000	-19,000	-84,000	-114,000	-145,000	-129,000	-184,000	-258,000	-131,000			-29,000	-721,000	-148,000	-21,000	-12,000	-1,000	-84,000	-21,000		0	-46,000	-6,000
free cash flows	-3,087,000	-701,000	3,617,000	4,684,000	-1,202,000	-210,000	5,377,000	-965,000	-3,022,000	3,264,000	1,815,000	-212,000	-267,000	-3,045,000	596,000	-1,396,000	-392,000	-159,000	-240,000	-893,000	-1,857,000	-2,005,000	-1,055,000	1,631,000	-1,088,000	1,595,000	-4,061,000	-285,000	-3,183,000			-1,603,000	-1,575,000	-1,905,000	-2,117,000	-628,000	-798,000	-709,000	-239,000		-604,000	217,000	166,000
cash flows from investing activities:
purchases of property and equipment	-263,000	-156,000	-284,000	-1,184,000	-79,000	-15,000	-84,000	-198,000	-86,000	-73,000	-59,000	-22,000	-11,000	-147,000	-47,000	-12,000	-28,000	-73,000	-50,000	-49,000	-21,000	-19,000	-84,000	-114,000	-145,000	-129,000	-184,000	-258,000	-131,000	-67,000	-21,000	-29,000	-721,000	-148,000	-21,000	-12,000	-1,000	-84,000	-21,000	-185,000
proceeds from maturities of investments	0	0	18,000,000	8,000,000
purchases of investments				0	-15,642,000																				7,000
net cash from investing activities	-263,000	-156,000	17,716,000	6,816,000	-7,721,000	-17,667,000	-84,000	-198,000	-86,000	-73,000	-59,000	-22,000	-11,000	-147,000	-47,000	-14,000	-26,000	-73,000	-50,000	-49,000	-21,000	-19,000	-84,000	5,851,000	-138,000	-6,101,000	-184,000	-258,000	-131,000	-67,000	-21,000	-29,000	-721,000	-148,000	-21,000	-12,000	-1,000	-84,000	-21,000		-52,000	-46,000	-6,000
cash flows from financing activities:
proceeds from issuance of common stock under employee plans	178,000	774,000	318,000	597,000	853,000	657,000	455,000																									52,000	0	237,000	223,000	302,000	38,000
shares repurchased for tax withholdings on vesting of restricted stock units	-20,000	-448,000	-1,012,000	-380,000	-464,000	-37,000	-1,179,000
proceeds from issuance of common stock from public offering, net of issuance costs				-33,000				0	0
net cash from financing activities	158,000	254,000	-694,000	184,000	7,242,000	620,000	-724,000	361,000	26,000	25,239,000	135,000	77,000	1,518,000	175,000	190,000	1,749,000	130,000	231,000	62,000	-5,986,000	123,000	203,000	109,000	198,000	126,000	367,000	234,000	16,026,000	47,000	5,668,000	94,000	46,000	2,000,000	237,000	223,000	3,947,000	-489,000	2,416,000	538,000		9,000	-107,000	-95,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	-4,000	6,000	-22,000
net increase in cash, cash equivalents and restricted cash	-2,933,000	-441,000	20,901,000	12,866,000	-1,616,000	-17,273,000	4,663,000			28,501,000	1,948,000				880,000
cash, cash equivalents and restricted cash, beginning of period	0	0	30,204,000		0	0	31,564,000		0	0	4,662,000		0	0	5,513,000		0	0	5,508,000
cash, cash equivalents and restricted cash, end of period	-2,933,000	-441,000	51,105,000		-1,616,000	-17,273,000	36,227,000		-3,011,000	28,501,000	6,610,000				6,393,000		-244,000	36,000	5,346,000
issuance cost of common stock offering
non-cash lease expenses			172,000
stock-based compensation
non-cash operating lease expense				78,000
net gain from dissolution of aehr test systems japan												0	0	0	-2,186,000
income tax benefit related to dissolution of aehr test systems japan												0	0	0	-215,000
gain from forgiveness of ppp loan								0	0	0	-1,698,000
trade and other accounts receivable				-5,202,000	-1,204,000
prepaid expenses and other																																43,000	105,000	62,000	-201,000	163,000	-74,000	-9,000	-46,000	72,000	23,000	35,000	-181,000	4,000	182,000	-66,000	-127,000	48,000	-30,000
customer deposits and deferred revenue				2,002,000	-2,854,000	366,000	855,000	-3,803,000	-3,971,000	6,829,000	3,141,000	-379,000	592,000	-331,000	214,000	-227,000	-1,454,000	1,145,000	-1,006,000	227,000	-813,000	-378,000	609,000	-718,000	-586,000	262,000	-440,000	2,527,000	-58,000	-1,685,000	946,000	-312,000	731,000	-524,000	-2,804,000	3,039,000	920,000	37,000	-294,000	-293,000	-707,000	-393,000	409,000
other long-term liabilities												4,000
line of credit (repayments) borrowings								0																																		-471,000	-154,000	-114,000
effect of exchange rates on cash, cash equivalents and restricted cash				-2,000	-14,000	-31,000	10,000	68,000	-15,000	-2,000	-2,000		38,000	6,000	94,000
cash, cash equivalents and restricted cash, beginning of year
cash, cash equivalents and restricted cash, end of year
supplemental cash flow information:
cash paid during the year for:
income taxes
interest
supplemental disclosure of non-cash flow information:
net transfer of equipment between inventory and property and equipment
prepaid expenses and other assets					29,000				32,000				-137,000				-24,000
line of credit repayments										0	-1,400,000																									-115,000	-527,000
loss on disposal of property plant equipment
proceeds from long-term debt
proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards									26,000	1,209,000	1,535,000		118,000	175,000	190,000		130,000	231,000	62,000			203,000	109,000		126,000				47,000
net increase in cash, cash equivalent and restricted cash
recovery of doubtful accounts																					0
loss on disposal of assets																																											9,000
deferred rent																				2,000	4,000	2,000	82,000													0	0	0	-8,000
repayment of convertible notes
line of credit borrowings												0																																		233,000	44,000	692,000
effect of exchange rates on cash, cash equivalents and restricted cash
gain on disposal of fixed asset
proceeds from sales of property and equipment																																								0
net decrease in cash, cash equivalent and restricted cash
net decrease in cash, cash equivalents and restricted cash																		36,000	-162,000
cash, cash equivalents and restricted cash, end of period
transfers of property and equipment to inventories																										0	372,000				372,000
adjustments to reconcile net income to net cash from operating activities: stock-based compensation expense															270,000
effect of exchange rates on cash and cash equivalents																	16,000	-36,000	16,000	7,000	32,000	-60,000	-38,000	-23,000	73,000	-24,000	17,000	23,000	21,000	-129,000	86,000
(recovery of) benefit from doubtful accounts																								-55,000	11,000											14,000	-13,000	-11,000	-20,000								-1,000
amortization of debt issuance costs																													44,000	45,000	44,000	51,000	44,000	45,000	37,000
proceeds from issuance of common stock under public offering, net of issuance costs
proceeds from issuance of common stock under private placement, net of issuance costs																												0	0								0
net increase in cash and cash equivalents																								7,771,000	-882,000	-4,034,000	-3,810,000	15,764,000	-3,115,000			-1,533,000	517,000	-1,698,000	-1,874,000	3,253,000			266,000			59,000	111,000
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
fair value of common stock issued to settle accounts payable
proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards
net decrease in cash and cash equivalents																					-1,702,000	-1,862,000	-984,000
cash and cash equivalents, beginning of period																					0	0	16,848,000		0	0	17,803,000		0	0	939,000		0	0	5,527,000		0	0	1,809,000		0	0	2,324,000		0	0	2,073,000		0
cash and cash equivalents, end of period																					-1,702,000	-1,862,000	15,864,000		-882,000	-4,034,000	13,993,000		-3,115,000	2,812,000	2,342,000		517,000	-1,698,000	3,653,000		-1,322,000	1,521,000	2,075,000		-648,000	59,000	2,435,000		189,000	-709,000	1,901,000		-151,000
loss on disposal of asset
line of credit borrowings (repayments)																																0							223,000
proceeds from issuance of convertible notes
net change in capitalized stock-based compensation
line of credit converted to convertible notes
adjustments to reconcile net income to net cash provided by operating activities:
proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards																											234,000
fair value of common stock issued to settle accounts payable																															323,000
provision (recovery of) for doubtful accounts
amortization of debt issuance cost
net cash from operating activities																															1,244,000
proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards																															94,000
net increase in cash and cash equivalents																															1,403,000
net change in capitalized share-based compensation																																			-20,000		-7,000								-42,000
gain on disposal of asset
proceeds from issuance of common stock under private placement, net of issuance cost
non-cash transactions:
benefit from (recovery of) doubtful accounts																																	-9,000	-2,000	19,000								7,000
effect of exchange rates on cash																																	92,000	-30,000	20,000		-35,000	-186,000	-33,000		-1,000	-51,000	40,000		-162,000	-93,000	5,000		-78,000
proceed from issuance of long-term debt
net increase in cash andcash equivalents
proceeds from issuance of common stock and exercise of stock options																																							315,000		79,000	364,000	59,000
adjustments to reconcile net income to net cash
used in operating activities:
(gain) loss on disposal of asset
gain on sale of long-term investment																																																0	0
income tax payable																																								-30,000	12,000	-2,000	-45,000	-20,000	1,000	13,000	1,000	-34,000	11,000
net cash used in
operating activities																																														-957,000	-272,000	-1,669,000	-787,000
proceeds from sales of investments
net cash provided by
investing activities.
proceeds from issuance of common stock
under private placement
under employee plans
financing activities																																														346,000	111,000	746,000	716,000
effect of exchange rates on cash and
cash equivalents																																														-709,000	-172,000	1,067,000	-151,000
net increase in cash and
non cash transactions:
deferred lease commitment																																									-24,000	-24,000	-23,000	-19,000				-16,000	-14,000
purchase of property and equipment																																										-46,000	-6,000	-1,000	-105,000	-5,000	-16,000	-25,000	-2,000
proceeds from sale of investments																																																0	0
investing activities																																														-5,000	-16,000	-25,000	-2,000
accrued expenses and deferred revenue																																													-289,000	224,000	16,000	569,000	-425,000
deferred lease commitment, net of current																																														-19,000	-18,000
and exercise of stock options																																														113,000	67,000	54,000	0
net decrease in cash and
adjustments to reconcile net income to
net cash from operating
activities:
stock based compensation expense																																															169,000
provided by operating activities:
stock compensation expense																																																	182,000

We provide you with 20 years of cash flow statements for Aehr Test Systems stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Aehr Test Systems stock. Explore the full financial landscape of Aehr Test Systems stock with our expertly curated income statements.

The information provided in this report about Aehr Test Systems stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.